Neumora Therapeutics (NMRA) Tax Rate (2024 - 2026)

Neumora Therapeutics' quarterly Tax Rate came in at 0.06% in Q1 2026, up 10.0% year-on-year from 0.05% in Q1 2025, and down 18.38% quarter-over-quarter from 0.05% in Q2 2025.

Neumora Therapeutics has reported Tax Rate for 3 years, with the latest figure at 0.06% in Q1 2026.

  • For the quarter ending Q1 2026, Tax Rate rose 10.0% year-over-year to 0.06%; the trailing twelve-month figure through Mar 2026 stood at 0.02% (up 9.0% YoY), and the FY2025 full-year result was 0.05%, up 2.0% from the prior year.
  • Tax Rate for Q1 2026 stood at 0.06%, down from 0.05% in the prior quarter.
  • The five-year high for Tax Rate was 0.05% in Q2 2025, with the low at 0.21% in Q2 2024.
  • Average Tax Rate over 3 years is 0.11%, with a median of 0.07% recorded in 2024.
  • Year-over-year, Tax Rate gained 17 bps in 2025 and advanced 10 bps in 2026.
  • Tracing NMRA's Tax Rate over 3 years: stood at 0.07% in 2024, then surged by 35 bps to 0.05% in 2025, then decreased by 18 bps to 0.06% in 2026.
  • The last three Tax Rate figures came in at 0.06% (Q1 2026), 0.05% (Q2 2025), and 0.15% (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 57.14
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 5.61
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 17.68
7 Evaxion A 62.56 Bn 62.54 Bn - -6.79
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 12.51
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 7.07
10 Neumora Therapeutics 328.27 Mn 328.27 Mn - -0.06

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -0.06
Mar 31, 2026 -0.06
Jun 30, 2025 -0.05
Jun 30, 2025 -0.05
Mar 31, 2025 -0.15
Mar 31, 2025 -0.15
Sep 30, 2024 -0.07
Sep 30, 2024 -0.07
Jun 30, 2024 -0.21
Jun 30, 2024 -0.21